Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat

Perinatal hypoxic-ischemic (HI) brain injury occurs in 1 in 1,000 live births and remains the main cause of neurological disability and death in term infants. Cytotherapy has recently emerged as a novel treatment for tissue injury. In particular, mesenchymal stem cells (MSCs) are thought to have the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiyama, Yuichiro, Sato, Yoshiaki, Kitase, Yuma, Suzuki, Toshihiko, Kondo, Taiki, Mikrogeorgiou, Alkisti, Horinouchi, Asuka, Maruyama, Shoichi, Shimoyama, Yoshie, Tsuji, Masahiro, Suzuki, Satoshi, Yamamoto, Tokunori, Hayakawa, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141968/
https://www.ncbi.nlm.nih.gov/pubmed/30254603
http://dx.doi.org/10.3389/fneur.2018.00757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141968/
https://www.ncbi.nlm.nih.gov/pubmed/30254603
http://dx.doi.org/10.3389/fneur.2018.00757

Ejemplares similares